Mechanisms and therapeutic implications of hypermutation in gliomas
Broad Institute · Centre National de la Recherche Scientifique · +24 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
694
total citations
- FWCI
- 55.96
- Percentile
- 100%
- References
- 74
Citations per year
Authors
78- MTMehdi TouatCorresponding
Broad Institute, Centre National de la Recherche Scientifique, Harvard University, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Dana-Farber Cancer Institute, Institut du Cerveau
- YYYvonne Y. Li
Broad Institute, Harvard University, Dana-Farber Cancer Institute
- ANAdam N. Boynton
Broad Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
- LFLiam F. Spurr
Broad Institute, Harvard University, Dana-Farber Cancer Institute
- JBJ. Bryan Iorgulescu
Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Somatic hypermutation
- Temozolomide
- DNA mismatch repair
- Cancer research
- Microsatellite instability
- Biology
- Mutation
- DNA repair
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.